Global Pharmaceutical Glass Packaging Market to Reach $26.6 Billion by 2027

Abstract: Global Pharmaceutical Glass Packaging Market to Reach $26. 6 Billion by 2027. Amid the COVID-19 crisis, the global market for Pharmaceutical Glass Packaging estimated at US$15.

New York, July 28, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Pharmaceutical Glass Packaging Industry" - https://www.reportlinker.com/p05900061/?utm_source=GNW
7 Billion in the year 2020, is projected to reach a revised size of US$26.6 Billion by 2027, growing at a CAGR of 7.9% over the analysis period 2020-2027. Bottles, one of the segments analyzed in the report, is projected to record a 6.1% CAGR and reach US$8.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Vials segment is readjusted to a revised 8.6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $4.6 Billion, While China is Forecast to Grow at 9.2% CAGR

The Pharmaceutical Glass Packaging market in the U.S. is estimated at US$4.6 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$4 Billion by the year 2027 trailing a CAGR of 9.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.8% and 7.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.3% CAGR.

Ampoules Segment to Record 9.7% CAGR

In the global Ampoules segment, USA, Canada, Japan, China and Europe will drive the 9.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.7 Billion in the year 2020 will reach a projected size of US$5.2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.1 Billion by the year 2027, while Latin America will expand at a 10.3% CAGR through the analysis period.

Select Competitors (Total 41 Featured)

• Arab Pharmaceutical Glass Co.

• Ardagh Group S.A.

• Beatson Clark

• Bormioli Rocco SpA

• Corning, Inc.

• Gerresheimer AG

• Nipro Corporation

• Piramal Glass

• SCHOTT Pharmaceutical Packaging

• SGD Pharma

• Shandong Qidu Pharmaceutical Co., Ltd.

• Sisecam Group

• Stevanato Group S.p.A.

• Stölzle-Oberglas Gmbh

• West Pharmaceutical Services, Inc.

Read the full report: https://www.reportlinker.com/p05900061/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
COVID-19 Impact on Pharmaceutical Packaging Market
EXHIBIT 1: Growing COVID-19 Cases and Efforts to Develop
Vaccines Presents Opportunity for Pharmaceutical Glass
Packaging Market: Top Countries Ranked by Number of COVID-19
Cases
COVID-19 to Restructure the Pharmaceutical Supply Chain Management
Pharmaceutical Companies Devise Innovative Strategies for
Streamlining Supply Chain Networks
Unprecedented Global Push to Expedite COVID-19 Vaccine
Development to Spur Demand for Glass Packaging
EXHIBIT 2: COVID-19 Vaccines in Pipeline by Technology and
Clinical Stage
Efforts to Boost Manufacturing of Glass Vials and Prefilled
Syringes for COVID-19 Vaccine Gain Traction
Fears of Glass Vial Shortage Prompts Flurry of Industry Activities
Glass Packaging: Sustainable, Green, and Pure Form of Packaging
An Introduction to Pharmaceutical Glass Packaging
Types of Glass Containers Used for Packaging in Pharmaceutical
Industry
Pharmaceutical Glass Packaging Product Types
Key Advantages & Disadvantages of Glass Containers
Global Market Prospects & Outlook
Glass Bottles: The Largest Product Type
Generic Drugs Represent the Largest Segment
Developed Regions Lead the Pharmaceutical Glass Packaging Market
Growth of Pharmaceutical Manufacturing in Developing Economies
Supports Market
Competition
World Brands
Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Strong Rise in Pharmaceutical Sales to Drive Demand for Glass
Packaging Solutions
EXHIBIT 3: Global Prescription Drug Sales (In US$ Billion) for
the Years 2017, 2019, 2021, 2023 & 2025
Rapid Growth of Generic Drugs Augurs Well for Glass Packaging
Market
EXHIBIT 4: Global Generic Drugs Market Size (in $ Billion) for
the Years 2016, 2019, 2020 & 2025
Increasing Significance of Biologic Drugs Fuels Innovations in
Packaging and Delivery Techniques
EXHIBIT 5: Global Biologic Drugs Market Size (in US$ Billion)
for the Years 2019, 2022 & 2025
Aging Population, Increasing Burden of Chronic Disease and
Consequent Rise in Demand for Injectables Drugs Augurs Well
for Glass Packaging
EXHIBIT 6: Global Aging Population Statistics for the 65+ Age
Group in Million by Geographic Region for the Years 2019,
2025, 2035 and 2050
EXHIBIT 7: Global Cancer Incidence: Number of New Cancer Cases
in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
EXHIBIT 8: World Diabetes and Population Statistics (2019, 2030 &
2045)
Contract Packaging Trend Augurs Well for the Pharma Glass
Packaging Market
Ampoules Emerge as a Preferred Packaging Option for Pharma
Companies
Parenteral Packaging Market Drives Demand for Glass Vials &
Ampoules
EXHIBIT 9: Parenteral Packaging Market by Product (in %) for 2020E
Silica Bottles Facilitate Targeted Drug Delivery
Innovative Glass Packaging Solutions Help Improve Quality of Drugs
Innovations & Advancements Drive Market Growth
SCHOTT Offers syriQ BioPure® and SCHOTT TOPPAC® Syringes
Corning Creates Boron-Free Valor® Glass
Recyclability and Sustainability Increases Commodity Value of
Glass, Paving Way for Use in Pharma Sector
Impending Phase-out of Plastic Brings to Light the Importance
of Glass for Pharmaceutical Packaging Companies
Glass Flakes: A Key Concern for the Pharmaceutical Glass
Packaging Manufacturers
Aluminosilicate Glass Emerges as a Solution to the Issue of
Glass Flakes
Product Recall Incidents Likely to Hamper Market Stability
Alternative Materials Present A Threat to Glass Packaging in
Pharmaceutical Industry
EXHIBIT 10: Global Pharmaceutical Packaging Market by Material
(in %): 2020E
High Cost of Glass Packaging Containers: A Major Market Restraint
EXHIBIT 11: Cost Breakdown for Container Glass by Components
Emphasis on Product Integrity Drives Need for Anti-Counterfeit
Pharmaceutical Packaging

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Pharmaceutical
Glass Packaging by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Pharmaceutical Glass
Packaging by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Pharmaceutical Glass
Packaging by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa Markets for Years 2012,
2020 & 2027

Table 4: World Current & Future Analysis for Bottles by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for Bottles by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Bottles by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Vials by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Vials by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Vials by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Ampoules by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Ampoules by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Ampoules by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Cartridges &
Syringes by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Cartridges & Syringes by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Cartridges & Syringes
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Generic by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 17: World Historic Review for Generic by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 18: World 15-Year Perspective for Generic by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Branded by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 20: World Historic Review for Branded by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 21: World 15-Year Perspective for Branded by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Biologic by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 23: World Historic Review for Biologic by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 24: World 15-Year Perspective for Biologic by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Pharmaceutical Packaging Market in the US: An Overview
EXHIBIT 12: US Pharmaceutical Packaging Market by Material
(in %) for 2020E
Table 25: USA Current & Future Analysis for Pharmaceutical
Glass Packaging by Product Type - Bottles, Vials, Ampoules and
Cartridges & Syringes - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 26: USA Historic Review for Pharmaceutical Glass
Packaging by Product Type - Bottles, Vials, Ampoules and
Cartridges & Syringes Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 27: USA 15-Year Perspective for Pharmaceutical Glass
Packaging by Product Type - Percentage Breakdown of Value Sales
for Bottles, Vials, Ampoules and Cartridges & Syringes for the
Years 2012, 2020 & 2027

Table 28: USA Current & Future Analysis for Pharmaceutical
Glass Packaging by Drug Type - Generic, Branded and Biologic -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 29: USA Historic Review for Pharmaceutical Glass
Packaging by Drug Type - Generic, Branded and Biologic Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 30: USA 15-Year Perspective for Pharmaceutical Glass
Packaging by Drug Type - Percentage Breakdown of Value Sales
for Generic, Branded and Biologic for the Years 2012, 2020 &
2027

CANADA
Table 31: Canada Current & Future Analysis for Pharmaceutical
Glass Packaging by Product Type - Bottles, Vials, Ampoules and
Cartridges & Syringes - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 32: Canada Historic Review for Pharmaceutical Glass
Packaging by Product Type - Bottles, Vials, Ampoules and
Cartridges & Syringes Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 33: Canada 15-Year Perspective for Pharmaceutical Glass
Packaging by Product Type - Percentage Breakdown of Value Sales
for Bottles, Vials, Ampoules and Cartridges & Syringes for the
Years 2012, 2020 & 2027

Table 34: Canada Current & Future Analysis for Pharmaceutical
Glass Packaging by Drug Type - Generic, Branded and Biologic -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 35: Canada Historic Review for Pharmaceutical Glass
Packaging by Drug Type - Generic, Branded and Biologic Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 36: Canada 15-Year Perspective for Pharmaceutical Glass
Packaging by Drug Type - Percentage Breakdown of Value Sales
for Generic, Branded and Biologic for the Years 2012, 2020 &
2027

JAPAN
Table 37: Japan Current & Future Analysis for Pharmaceutical
Glass Packaging by Product Type - Bottles, Vials, Ampoules and
Cartridges & Syringes - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 38: Japan Historic Review for Pharmaceutical Glass
Packaging by Product Type - Bottles, Vials, Ampoules and
Cartridges & Syringes Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 39: Japan 15-Year Perspective for Pharmaceutical Glass
Packaging by Product Type - Percentage Breakdown of Value Sales
for Bottles, Vials, Ampoules and Cartridges & Syringes for the
Years 2012, 2020 & 2027

Table 40: Japan Current & Future Analysis for Pharmaceutical
Glass Packaging by Drug Type - Generic, Branded and Biologic -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 41: Japan Historic Review for Pharmaceutical Glass
Packaging by Drug Type - Generic, Branded and Biologic Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 42: Japan 15-Year Perspective for Pharmaceutical Glass
Packaging by Drug Type - Percentage Breakdown of Value Sales
for Generic, Branded and Biologic for the Years 2012, 2020 &
2027

CHINA
Market Overview
Table 43: China Current & Future Analysis for Pharmaceutical
Glass Packaging by Product Type - Bottles, Vials, Ampoules and
Cartridges & Syringes - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 44: China Historic Review for Pharmaceutical Glass
Packaging by Product Type - Bottles, Vials, Ampoules and
Cartridges & Syringes Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 45: China 15-Year Perspective for Pharmaceutical Glass
Packaging by Product Type - Percentage Breakdown of Value Sales
for Bottles, Vials, Ampoules and Cartridges & Syringes for the
Years 2012, 2020 & 2027

Table 46: China Current & Future Analysis for Pharmaceutical
Glass Packaging by Drug Type - Generic, Branded and Biologic -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 47: China Historic Review for Pharmaceutical Glass
Packaging by Drug Type - Generic, Branded and Biologic Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 48: China 15-Year Perspective for Pharmaceutical Glass
Packaging by Drug Type - Percentage Breakdown of Value Sales
for Generic, Branded and Biologic for the Years 2012, 2020 &
2027

EUROPE
Europe Pharmaceutical Packaging: A Prelude
EXHIBIT 13: Europe Pharmaceutical Packaging Materials Market by
Application (in %) for 2020E
Table 49: Europe Current & Future Analysis for Pharmaceutical
Glass Packaging by Geographic Region - France, Germany, Italy,
UK, Spain, Russia and Rest of Europe Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 50: Europe Historic Review for Pharmaceutical Glass
Packaging by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 51: Europe 15-Year Perspective for Pharmaceutical Glass
Packaging by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets for Years 2012, 2020 & 2027

Table 52: Europe Current & Future Analysis for Pharmaceutical
Glass Packaging by Product Type - Bottles, Vials, Ampoules and
Cartridges & Syringes - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 53: Europe Historic Review for Pharmaceutical Glass
Packaging by Product Type - Bottles, Vials, Ampoules and
Cartridges & Syringes Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 54: Europe 15-Year Perspective for Pharmaceutical Glass
Packaging by Product Type - Percentage Breakdown of Value Sales
for Bottles, Vials, Ampoules and Cartridges & Syringes for the
Years 2012, 2020 & 2027

Table 55: Europe Current & Future Analysis for Pharmaceutical
Glass Packaging by Drug Type - Generic, Branded and Biologic -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 56: Europe Historic Review for Pharmaceutical Glass
Packaging by Drug Type - Generic, Branded and Biologic Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 57: Europe 15-Year Perspective for Pharmaceutical Glass
Packaging by Drug Type - Percentage Breakdown of Value Sales
for Generic, Branded and Biologic for the Years 2012, 2020 &
2027

FRANCE
Table 58: France Current & Future Analysis for Pharmaceutical
Glass Packaging by Product Type - Bottles, Vials, Ampoules and
Cartridges & Syringes - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 59: France Historic Review for Pharmaceutical Glass
Packaging by Product Type - Bottles, Vials, Ampoules and
Cartridges & Syringes Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 60: France 15-Year Perspective for Pharmaceutical Glass
Packaging by Product Type - Percentage Breakdown of Value Sales
for Bottles, Vials, Ampoules and Cartridges & Syringes for the
Years 2012, 2020 & 2027

Table 61: France Current & Future Analysis for Pharmaceutical
Glass Packaging by Drug Type - Generic, Branded and Biologic -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 62: France Historic Review for Pharmaceutical Glass
Packaging by Drug Type - Generic, Branded and Biologic Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 63: France 15-Year Perspective for Pharmaceutical Glass
Packaging by Drug Type - Percentage Breakdown of Value Sales
for Generic, Branded and Biologic for the Years 2012, 2020 &
2027

GERMANY
Table 64: Germany Current & Future Analysis for Pharmaceutical
Glass Packaging by Product Type - Bottles, Vials, Ampoules and
Cartridges & Syringes - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 65: Germany Historic Review for Pharmaceutical Glass
Packaging by Product Type - Bottles, Vials, Ampoules and
Cartridges & Syringes Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 66: Germany 15-Year Perspective for Pharmaceutical Glass
Packaging by Product Type - Percentage Breakdown of Value Sales
for Bottles, Vials, Ampoules and Cartridges & Syringes for the
Years 2012, 2020 & 2027

Table 67: Germany Current & Future Analysis for Pharmaceutical
Glass Packaging by Drug Type - Generic, Branded and Biologic -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 68: Germany Historic Review for Pharmaceutical Glass
Packaging by Drug Type - Generic, Branded and Biologic Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 69: Germany 15-Year Perspective for Pharmaceutical Glass
Packaging by Drug Type - Percentage Breakdown of Value Sales
for Generic, Branded and Biologic for the Years 2012, 2020 &
2027

ITALY
Table 70: Italy Current & Future Analysis for Pharmaceutical
Glass Packaging by Product Type - Bottles, Vials, Ampoules and
Cartridges & Syringes - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 71: Italy Historic Review for Pharmaceutical Glass
Packaging by Product Type - Bottles, Vials, Ampoules and
Cartridges & Syringes Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 72: Italy 15-Year Perspective for Pharmaceutical Glass
Packaging by Product Type - Percentage Breakdown of Value Sales
for Bottles, Vials, Ampoules and Cartridges & Syringes for the
Years 2012, 2020 & 2027

Table 73: Italy Current & Future Analysis for Pharmaceutical
Glass Packaging by Drug Type - Generic, Branded and Biologic -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 74: Italy Historic Review for Pharmaceutical Glass
Packaging by Drug Type - Generic, Branded and Biologic Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 75: Italy 15-Year Perspective for Pharmaceutical Glass
Packaging by Drug Type - Percentage Breakdown of Value Sales
for Generic, Branded and Biologic for the Years 2012, 2020 &
2027

UNITED KINGDOM
Table 76: UK Current & Future Analysis for Pharmaceutical Glass
Packaging by Product Type - Bottles, Vials, Ampoules and
Cartridges & Syringes - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 77: UK Historic Review for Pharmaceutical Glass Packaging
by Product Type - Bottles, Vials, Ampoules and Cartridges &
Syringes Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 78: UK 15-Year Perspective for Pharmaceutical Glass
Packaging by Product Type - Percentage Breakdown of Value Sales
for Bottles, Vials, Ampoules and Cartridges & Syringes for the
Years 2012, 2020 & 2027

Table 79: UK Current & Future Analysis for Pharmaceutical Glass
Packaging by Drug Type - Generic, Branded and Biologic -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 80: UK Historic Review for Pharmaceutical Glass Packaging
by Drug Type - Generic, Branded and Biologic Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 81: UK 15-Year Perspective for Pharmaceutical Glass
Packaging by Drug Type - Percentage Breakdown of Value Sales
for Generic, Branded and Biologic for the Years 2012, 2020 &
2027

SPAIN
Table 82: Spain Current & Future Analysis for Pharmaceutical
Glass Packaging by Product Type - Bottles, Vials, Ampoules and
Cartridges & Syringes - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 83: Spain Historic Review for Pharmaceutical Glass
Packaging by Product Type - Bottles, Vials, Ampoules and
Cartridges & Syringes Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 84: Spain 15-Year Perspective for Pharmaceutical Glass
Packaging by Product Type - Percentage Breakdown of Value Sales
for Bottles, Vials, Ampoules and Cartridges & Syringes for the
Years 2012, 2020 & 2027

Table 85: Spain Current & Future Analysis for Pharmaceutical
Glass Packaging by Drug Type - Generic, Branded and Biologic -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 86: Spain Historic Review for Pharmaceutical Glass
Packaging by Drug Type - Generic, Branded and Biologic Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 87: Spain 15-Year Perspective for Pharmaceutical Glass
Packaging by Drug Type - Percentage Breakdown of Value Sales
for Generic, Branded and Biologic for the Years 2012, 2020 &
2027

RUSSIA
Table 88: Russia Current & Future Analysis for Pharmaceutical
Glass Packaging by Product Type - Bottles, Vials, Ampoules and
Cartridges & Syringes - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 89: Russia Historic Review for Pharmaceutical Glass
Packaging by Product Type - Bottles, Vials, Ampoules and
Cartridges & Syringes Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 90: Russia 15-Year Perspective for Pharmaceutical Glass
Packaging by Product Type - Percentage Breakdown of Value Sales
for Bottles, Vials, Ampoules and Cartridges & Syringes for the
Years 2012, 2020 & 2027

Table 91: Russia Current & Future Analysis for Pharmaceutical
Glass Packaging by Drug Type - Generic, Branded and Biologic -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 92: Russia Historic Review for Pharmaceutical Glass
Packaging by Drug Type - Generic, Branded and Biologic Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 93: Russia 15-Year Perspective for Pharmaceutical Glass
Packaging by Drug Type - Percentage Breakdown of Value Sales
for Generic, Branded and Biologic for the Years 2012, 2020 &
2027

REST OF EUROPE
Table 94: Rest of Europe Current & Future Analysis for
Pharmaceutical Glass Packaging by Product Type - Bottles,
Vials, Ampoules and Cartridges & Syringes - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 95: Rest of Europe Historic Review for Pharmaceutical
Glass Packaging by Product Type - Bottles, Vials, Ampoules and
Cartridges & Syringes Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 96: Rest of Europe 15-Year Perspective for Pharmaceutical
Glass Packaging by Product Type - Percentage Breakdown of Value
Sales for Bottles, Vials, Ampoules and Cartridges & Syringes
for the Years 2012, 2020 & 2027

Table 97: Rest of Europe Current & Future Analysis for
Pharmaceutical Glass Packaging by Drug Type - Generic, Branded
and Biologic - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 98: Rest of Europe Historic Review for Pharmaceutical
Glass Packaging by Drug Type - Generic, Branded and Biologic
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 99: Rest of Europe 15-Year Perspective for Pharmaceutical
Glass Packaging by Drug Type - Percentage Breakdown of Value
Sales for Generic, Branded and Biologic for the Years 2012,
2020 & 2027

ASIA-PACIFIC
Market Overview
Asia-Pacific to Witness Introduction of New Syringes and Ampoules
Table 100: Asia-Pacific Current & Future Analysis for
Pharmaceutical Glass Packaging by Geographic Region -
Australia, India, South Korea and Rest of Asia-Pacific Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2020 through 2027 and % CAGR

Table 101: Asia-Pacific Historic Review for Pharmaceutical
Glass Packaging by Geographic Region - Australia, India, South
Korea and Rest of Asia-Pacific Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 102: Asia-Pacific 15-Year Perspective for Pharmaceutical
Glass Packaging by Geographic Region - Percentage Breakdown of
Value Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2012, 2020 & 2027

Table 103: Asia-Pacific Current & Future Analysis for
Pharmaceutical Glass Packaging by Product Type - Bottles,
Vials, Ampoules and Cartridges & Syringes - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 104: Asia-Pacific Historic Review for Pharmaceutical
Glass Packaging by Product Type - Bottles, Vials, Ampoules and
Cartridges & Syringes Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 105: Asia-Pacific 15-Year Perspective for Pharmaceutical
Glass Packaging by Product Type - Percentage Breakdown of Value
Sales for Bottles, Vials, Ampoules and Cartridges & Syringes
for the Years 2012, 2020 & 2027

Table 106: Asia-Pacific Current & Future Analysis for
Pharmaceutical Glass Packaging by Drug Type - Generic, Branded
and Biologic - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 107: Asia-Pacific Historic Review for Pharmaceutical
Glass Packaging by Drug Type - Generic, Branded and Biologic
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 108: Asia-Pacific 15-Year Perspective for Pharmaceutical
Glass Packaging by Drug Type - Percentage Breakdown of Value
Sales for Generic, Branded and Biologic for the Years 2012,
2020 & 2027

AUSTRALIA
Table 109: Australia Current & Future Analysis for
Pharmaceutical Glass Packaging by Product Type - Bottles,
Vials, Ampoules and Cartridges & Syringes - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 110: Australia Historic Review for Pharmaceutical Glass
Packaging by Product Type - Bottles, Vials, Ampoules and
Cartridges & Syringes Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 111: Australia 15-Year Perspective for Pharmaceutical
Glass Packaging by Product Type - Percentage Breakdown of Value
Sales for Bottles, Vials, Ampoules and Cartridges & Syringes
for the Years 2012, 2020 & 2027

Table 112: Australia Current & Future Analysis for
Pharmaceutical Glass Packaging by Drug Type - Generic, Branded
and Biologic - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 113: Australia Historic Review for Pharmaceutical Glass
Packaging by Drug Type - Generic, Branded and Biologic Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 114: Australia 15-Year Perspective for Pharmaceutical
Glass Packaging by Drug Type - Percentage Breakdown of Value
Sales for Generic, Branded and Biologic for the Years 2012,
2020 & 2027

INDIA
Indian Glass Vial Manufacturers Prepare for Demand Surge for
Bottling COVID-19 Vaccines
Changing Product Portfolio Composition Drives Spending on
Packaging
Table 115: India Current & Future Analysis for Pharmaceutical
Glass Packaging by Product Type - Bottles, Vials, Ampoules and
Cartridges & Syringes - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 116: India Historic Review for Pharmaceutical Glass
Packaging by Product Type - Bottles, Vials, Ampoules and
Cartridges & Syringes Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 117: India 15-Year Perspective for Pharmaceutical Glass
Packaging by Product Type - Percentage Breakdown of Value Sales
for Bottles, Vials, Ampoules and Cartridges & Syringes for the
Years 2012, 2020 & 2027

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05900061/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001